R-pharm
Clinical trials sponsored by R-pharm, explained in plain language.
-
New MS drug copycat aims to match ocrevus in early trial
Disease control OngoingThis Phase 1 trial compares a new drug called RPH-035 to the approved MS drug Ocrevus. The study involves 180 adults with relapsing-remitting or secondary progressive multiple sclerosis who have flare-ups. Researchers are checking if RPH-035 behaves similarly in the body and has …
Phase: PHASE1 • Sponsor: R-Pharm • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New hope for advanced breast cancer: could a biosimilar match the standard?
Disease control OngoingThis study tests whether a new drug called RPH-051 works as well as the approved drug Perjeta when both are given with standard chemotherapy and another targeted therapy for people with HER2-positive breast cancer that has spread or cannot be removed. About 246 participants will …
Phase: PHASE3 • Sponsor: R-Pharm • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC